Clinical trials
Recruiting Overweight trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2025 | 7 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 4 |
| Eli Lilly and Company | 3 |
| Amgen | 2 |
| AstraZeneca | 2 |
| Hoffmann-La Roche | 2 |
| Shanghai Minwei Biotechnology Co., Ltd | 2 |
| Ikaria Bioscience Pty Ltd | 1 |
| Laekna Limited | 1 |
| Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 1 |
| University of Sydney | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 21 |
| Overweight | 21 |
| Sleep Apnea, Obstructive | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Atherosclerosis | 1 |
| Chronic Pain | 1 |
| Low Back Pain | 1 |
| Musculoskeletal Pain | 1 |
| Osteoarthritis | 1 |
| Osteoarthritis, Knee | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.